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Small non-coding RNAs (sRNAs) have received much attention in recent years due to their unique bio-
logical properties, which can efﬁciently and speciﬁcally tune target gene expressions in bacteria. Inspired
by natural sRNAs, recent works have proposed the use of artiﬁcial sRNAs (asRNAs) as genetic tools to
regulate desired gene that has been applied in several ﬁelds, such as metabolic engineering and bacterial
physiology studies. However, the rational design of asRNAs is still a challenge. In this study, we proposed
structure and length as two criteria to implement rational visualized and precise design of asRNAs. T7
expression system was one of the most useful recombinant protein expression systems. However, it was
deeply limited by the formation of inclusion body. To settle this problem, we designed a series of asRNAs
to inhibit the T7 RNA polymerase (Gene1) expression to balance the rate between transcription and
folding of recombinant protein. Based on the heterologous expression of Aspergillus oryzae Li-3 glucu-
ronidase in E. coli, the asRNA-antigene1-17bp can effectively decrease the inclusion body and increase
the enzyme activity by 169.9%.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
Recently, many sRNAs have been identiﬁed and characterized in
diverse organisms, particularly in Escherichia coli [1,2]. They have
been divided into cis-acting sRNA (csRNAs) and trans-acting sRNAs
(tsRNAs) [3]. The tsRNAs usually interact with the 50 un-translated
region (50UTR) or the translation initiation region (TIR) of target
mRNA by base pairing to regulate gene expression [4,5]. The tsRNAs
have been used as versatile and ﬂexible genetic tools inmany ﬁelds,
such as building logic gate in synthetic biology [6], knocking down
shunt pathway in metabolic engineering [7] and studying bacterial
physiology [8]. Since they are such a powerful genetic tool that
many groups have tried to develop asRNA to regulate gene
expression.
Yokobayashi et al. [9] developed an efﬁcient throughout
screening method for asRNAs by designing antisense domain as a
series of N bases, and fusing randomized antisense domain withnications Co., Ltd.
ng by Elsevier B.V. on behalf of KeAnatural sRNA scaffolds. However, the operation was complicated
and time consuming. To simplify the operation, Lee [10] rationally
designed the antisense domain of asRNA by introducing comple-
mentary base pairing with the front of target 24bp sequence. This
can deeply predigest the screening process, but the inhibition ef-
ﬁciency of designed asRNAs was dramatically different. Apart from
the antisense domain, Lee [11] and Ikebukuro [12] found that the
replacement of sRNA scaffolds could also improve the efﬁciency of
asRNAs. But sRNA scaffolds still need to screen efﬁcient antisense
domain to gain effect.
Based on previous study, the key step to implement reasonable
design of asRNAs was to design efﬁcient antisense domain, so we
focus on designing efﬁcient antisense domain.
T7 expression system was one of the most popular protein
expression systems [13] in which T7 RNA polymerase speciﬁcally
recognized T7 promoter [14] and elongated target mRNA 5-fold
faster than Escherichia coli RNA polymerases [15]. It includes two
parts: a plasmid containing T7 promoter and a factitial DE3 lyso-
genic host [16]. The DE3 lysogenic host has one copy of T7 RNA
polymerase gene (Gene1), which was pre-integrated into genome
to produce a very limited amount of T7 RNA Polymerase [17]. Thei Communications Co. This is an open access article under the CC BY-NC-ND license
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such approach and has been widely used for protein expression in
E. coli [18]. Although the amount of T7 RNA polymerase was very
limited, the speed of target gene transcriptionwas still too fast. The
high-level expression of recombinant proteins in Escherichia coli
often accumulate as insoluble aggregate in vivo as the inclusion
body [19] that severely limit its application.
We proposed that the inclusion body formation was due to the
high efﬁciency of T7 RNA polymerase. The inclusion body is very
likely to form due to the imbalance between the speed of target
gene transcription and protein folding. In this study, we developed
a series of asRNAs with different inhibition efﬁciency to ﬁne turn
Gene1 expression, which dramatically decreased the inclusion
body formation of T7 expression system.
2. Materials and methods
2.1. Strains, plasmids and culture condition
Escherichia coli Trans1-T1, TOP10 were selected as the clone
hosts and BL21 (DE3) as the expression host. Plasmids pEASY-Blunt
(TRANSGEN BIOTECH), pSB1A3, pSB1C3 and pSB1K3 (parts from
iGEM) were used to express asRNAs. To verify the function of asR-
NAs in optimizing the T7 expression system, plasmid pET-28a-
pGUS which expressed Aspergillus oryzae strain Li-3 glucuroni-
dase (GenBank: EU095019.1) was used as a model system. Since the
recombinant Aspergillus oryzae strain Li-3 glucuronidase (pGUS)
was expressed as the inclusion body that severely limit our study.
The strains were cultured in Luria-Bertani (LB) media at 37 C, 30 C
and 16 C with 200 rpm. Restriction enzymes and other modifying
enzymes were purchased from Thermo Fisher Scientiﬁc and used
according to the manufacturer's recommendations.
2.2. Plasmids and strains construction
Plasmid pSB1A3-system was constructed as a platform to ex-
press asRNA and to test its inhibition efﬁciency. This vector containsFig. 1. The schematic of the design and construction of asRNA expression and veriﬁcation
domain of the asRNA which was reversely complement base pairing with the target inhib
plasmid pSB1K3-veriﬁcation cassette was consisted of promoter PR, initial 24bp sequence fro
ATG. The plasmid pSB1A3 was consisted of both asRNA expression cassette and asRNA verboth asRNA expression cassette and veriﬁcation cassette that was
developed by BioBrick method [20] (Fig. 1). Besides, pSB1C3-asRNA
cassette was constructed to express asRNAs. And the pSB1K3-
veriﬁcation casette was constructed to verify the efﬁciency of
asRNAs.
By one step mutation, 24bp of ipgC, sicA* and esxC 5'leader
mRNA sequence were fused to the reporter gene LacZ to get
pSB1A3-system-ipgC, pSB1A3-system-sicA* and pSB1A3-system-
esxC. The complementary base pairing 24bp sequence of ipgC, sicA*
and esxC 5'leader mRNA were fused to sRNA scaffold MicC in the
same way to get pSB1A3-system-ipgC-anti-ipgC-24bp, pSB1A3-
system-sicA*-anti-sicA*-24bp and pSB1A3-system-exsC-anti-
exsC-24bp.
Besides, pSB1A3-system-ipgC-anti-ipgC-20bp and pSB1A3-
system-exsC-anti-exsC-20bp have been constructed to verify
whether the exposure of the antisense domain is necessary for
asRNA to show function. Furthermore, pSB1A3-system-ipgC-anti-
ipgC-15bp, pSB1A3-system-ipgC-anti-ipgC-10bp and pSB1A3-
system-ipgC-anti-ipgC-5bp were developed to test the efﬁciency
of the length of antisense domain.
To optimize the T7 expression system, asRNA-anti-gene1-17bp,
asRNA-anti-gene1-13bp and sRNA-anti-gene1-10bp were designed
to inhibit Gene1 expression independently to see whether these
asRNAs can decrease the inclusion body of pGUS and improve its
activity.
These asRNAs were developed by fusing 17bp, 13bp and 10bp
with complementary base pairing sequence of Gene1 5'mRNA
respectively to MicC scaffold. Using plasmid pSB1C3-sRNA cassette
as template the plasmids pSB1C3-asRNA cassette-anti-gene1-17bp,
pSB1C3-asRNA cassette-anti-gene1-13bp and pSB1C3-asRNA
cassette-anti-gene1-10bp were constructed. After ampliﬁed by
primer pair Primer SphI-fw & Primer BglII-rv, the PCR fragments
were digested with SphI and BglII, gel-puriﬁed, and then ligated
into plasmid pET-pGUSE, which was digested with the same
enzyme pair. The ﬁnal plasmids were named pET-28a-pGUSE-
asRNA-anti-gene1-17bp, pET-28a-pGUSE-asRNA-anti-gene1-13bp
and pET-28a-pGUSE-asRNA-anti-gene1-10bp respectively.system. The plasmid pSB1C3-asRNA cassette was consisted of promoter PR, antisense
ition sequence, MicC scaffold of asRNA and the bi-directional terminator T1/TE. The
m the target inhibition gene to fuse with the reporter gene LacZ which has deleted the
iﬁcation cassette. It was constructed by BioBrick method.
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supplementary materials Table 1 and the plasmids were listed in
supplementary materials Table 2.
2.3. Assay of enzyme activity
2.3.1. b -galactosidase
One milliliter actively growing culture of Escherichia coli was
taken in Eppendorf tube and centrifuged at 1000 rpm for 10 min.
The cell pellet was washed twice with phosphate buffer and re-
suspended in 500 mL of phosphate buffer (pH 7.0). The cells were
permeabilized by vortexing for 10 s with a solution containing
25 mL of toluene. To 100 mL of permeabilized cells, 10 mL ONPG was
added. The reaction mixture was incubated at 37 C in water bath
till the development of yellow. Reaction was stopped by adding
2 mL of 0.4 M Na2CO3 solution. Yellow intensity was determined at
420 nm using a spectrophotometer against a blank containing all
ingredients except the cell culture. b-galactosidase activity is
expressed as Millers unit calculated as formula given below:
Millers unit ¼ Absorbance420
Absorbance420  T  V
 1000
T ¼ time of reaction (minute)
V ¼ volume of the cell culture used (mL)Fig. 2. The secondary structure of designed asRNAs predicted by software RNA fold,
the inhibition efﬁciency of b-galactosidase activity and the binding free energy pre-
dicted by software RNAsubopt. (a) The secondary structure of asRNA anti-ipgC-24bp,
asRNA anti-sicA*-24bp, asRNA anti-exsC-24bp and the inhibition efﬁciency of these
asRNAs. (b) The secondary structure of asRNA anti-ipgC-20bp, asRNA anti-exsC-20bp
and the inhibition efﬁciency of these asRNAs. (c) The secondary structure of asRNA
anti-ipgC-20bp, asRNA anti-ipgC-15bp, asRNA anti-ipgC-10bp, asRNA anti-ipgC-5bp
and the inhibition efﬁciency of these asRNAs. (d) The binding free energy between
asRNA anti-ipgC-20bp, asRNA anti-ipgC-15bp, asRNA anti-ipgC-10bp and asRNA anti-
ipgC-5bp with target ipgC mRNA, respectively, that was predicted by software
RNAsubopt.2.3.2. Aspergillus oryzae strain Li-3 glucuronidase
The activity of pGUS was determined by the hydrolysis of p-
nitrophenyl (pNPG). The assaywas consisted of 20 mL crude enzyme
and 30 mL 1 mM pNPG. After incubation at 40 C for 10 min, the
reaction was stopped by mixing with 200 mL 0.4 mM Na2CO3. The
production of p-nitrophenol was assayed by using an ultraviolet
spectrophotometer (Hitachi) at 405 nm through the standard
curve.
2.4. Assay of protein production
The total crude protein concentration was determined using a
BCA Protein Assay Kit (Applygen, China). Semi-quantitative deter-
mination of recombinant protein concentration was analyzed by
SDS-PAGE and western-blot.
3. Results and discussion
3.1. Design and construction of plasmid system for characterizing
and verifying asRNAs
Small RNAs were composed of two functional parts: anti-sense
domain and scaffold domain [21]. The antisense domain binds to
target mRNA by base pairing to inhibit gene translation. A majority
of tsRNAs interact with 50UTR or TIR of target mRNA. The scaffold
domain recruits Hfq protein to avoid sRNA degradation by RNaseE
[22] and scaffold MicC [23e25] was frequently used in natural
sRNAs.
Plasmid pSB1A3-system was established as a platform to ex-
press asRNA and to detect the inhibition efﬁciency. It contained two
cassettes: expression cassette and veriﬁcation cassette. The
expression cassettewas consisted of PR promoter, MicC scaffold and
T1/TE terminator. The antisense domain was base paired with the
TIR of target gene and then inserted into the sequence between PR
promoter and MicC scaffold by one-step mutation. The veriﬁcation
cassette was consisted of PR promoter, LacZ gene which was fusedto target 24bp mRNA leader sequence and T1/TE terminator. The
schematic design of pSB1A3-system was shown in Fig. 1. The in-
hibition efﬁciency of asRNAs was characterized by b-galactosidase
activity.
3.2. Visualized and precise design for artiﬁcial sRNAs
Based on previous work, designing antisense domain was the
key step to develop asRNAs and the inhibition efﬁciency was
directly related to the antisense domain of asRNAs.
We developed asRNA-anti-ipgC-24bp, asRNA-anti-sicA*-24bp
and asRNA-anti-exsC-24bp. However, only asRNA-anti-sicA*-24bp
decreased the expression level by 38%. The inhibition efﬁciency of
other asRNAs was indistinctive (Fig. 2-a). By analyzing the second-
ary structure of these three asRNAs through web open software
RNAfold (http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi), it was
found that only asRNA-anti-sicA*-24bp showed exposed antisense
Fig. 2. (continued).
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scaffold which was very important to recruit Hfq protein. So we
proposed a hypothesis that the exposure of asRNA antisense domainFig. 3. The SDS-PAGE and western-blot results of the inducible expressed protein at 16and the maintenance of asRNA scaffold nature structure were very
important to asRNAs inhibition efﬁciency. This may be due to that
the exposed antisense domain was easy to bind with target mRNA
while the natural asRNA scaffold was important to recruit RNA
charpon Hfq protein to avoid being degraded by RNaseE.
After redesigning asRNA-anti-ipgC-20bp and asRNA-anti-exsC-
20bp to expose their antisense domain and maintain the natural
MicC scaffold structure, these two asRNAs worked effectively
(Fig. 2-b). Therefore, we proposed a criterion for asRNA design: the
exposure of antisense domain out of scaffold and the maintenance
of scaffold structure are necessary to implement reasonable design
asRNAs, which is named as structure condition. The structure of
antisense domain can be screened by software RNA fold and the
virtual screening optimization is simple.
Furthermore, we designed asRNA-anti-ipgC-15bp, asRNA-anti-
ipgC-10bp and asRNA-anti-ipgC-5bp which meet the structure
requirement but in different length of antisense domain. We found
that the longer antisense domain showed better performance.
RNAsubopt analysis indicated that the longer antisense domain had
lower binding free energy, thus resulting in the higher efﬁciency of
asRNA (Fig. 2-c and d). We named it length condition.
Based on the proposed structure and length condition, we
implemented visualized screening antisense domain structure and
precise design of antisense domain length of asRNAs for regulating
protein expression. Furthermore, we developed asRNAs which met
these two conditions to optimize prokaryotic T7 expression system.3.3. Regulating and balancing soluble protein expression by asRNAs
in E. coli
The pET-20a and BL21 (DE3) from Novagen is a representative
T7 expression system and has been widely used for protein
expression in E. coli. However, it is easy to form the inclusion body
and decrease enzyme activity that has limited its application
severely. Although the inclusion body can be decreased by opti-
mizing inducer concentration and induce condition, this cost a lot
of time and energy on monotonous repetitive work. In this study,C, 30 C and 37 C. The white square is pGUS with molecular weight of 67.6 KDa.
Fig. 4. The secondary structure of asRNA anti-gene1-17bp, asRNA anti-gene1-13bp and
asRNA anti-gene1-10bp predicted by software RNA fold and the improved percentage
of pGUS activity with 1 mM IPTG in 16 C cultured 20 h, 30 C cultured 8 h and 37 C
cultured 8 h condition respectively. (a) The secondary structure of asRNA anti-gene1-
17bp, asRNA anti-gene1-13bp and asRNA anti-gene1-10bp predicted by software RNA
fold. The improved percentage of pGUS activity with 1 mM IPTG at 16 C, cultured 20 h.
(b) The improved activity of pGUS by using the asRNAs.with 1 mM IPTG in 30 C,
cultured 8 h. (c) The improved percentage of pGUS activity with 1 mM IPTG in 37 C,
cultured 8 h.
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T7 RNA polymerase which is achieved by using asRNAs to inhibit
Gene1 expression, which can balance the speed between target
gene transcription and translation to allow the correct folding of
target protein. We designed asRNA anti-gene1-17bp, asRNA anti-
gene1-13bp and asRNA anti-gene1-10bp to inhibit Gene1 expres-
sion in three levels. The amount of soluble proteinwas detected via
SDS-PAGE, western-blot and the activity of pGUS. The three asRNAs
all worked effectively and asRNA antigene1-17bp had the best
performance and the soluble protein and enzyme activity was
increased by 169.9%, as shown in Figs. 3 and 4. In addition, it took
only two days to design asRNAs and regulate protein expression,
indicating that using asRNAs to regulate protein expression and
decrease the inclusion body is a ﬂexible and time-saving method.
4. Conclusions
In this paper, we have proposed two criteria for rational
designing asRNAs: structure and length. The structure condition
was to expose the antisense domain out of asRNA scaffold and
maintain the natural structure of the asRNA scaffold. This operation
can be visualized screening by software RNAfold. The structure
condition was the length offer antisense domain was in positive
correlation with the inhibition efﬁciency, which may be due to the
longer antisense domain had the lower binding free energy thus
resulting in the high efﬁciency of asRNA. But it was easy to form the
stem-loop structure for a long antisense domain that may be hard
to meet the structure condition of rational design asRNAs, so these
two criteria should be met simultaneously to implement the
visualized and precise design of asRNAs.
To expand the application of asRNAs, we developed three asR-
NAs in different inhibition level to inhibit T7 RNA Polymerase
(Gene1) expression. By this way, we decreased the inclusion body
on molecular level effectively in two days. That is a ﬂexible and
time-saving method to optimize T7 expression system in Escher-
ichia coli.
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